Medicina Legal, Psiquiatría y Patología
Saila
Technical University Munich
Múnich, AlemaniaTechnical University Munich-ko ikertzaileekin lankidetzan egindako argitalpenak (18)
2024
-
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis
The Lancet Psychiatry, Vol. 11, Núm. 1, pp. 36-46
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
Psychological Medicine, Vol. 53, Núm. 13, pp. 5986-5991
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e7
-
The role of depression in the prediction of a “late” remission in first-episode psychosis: An analysis of the OPTiMiSE study
Schizophrenia Research, Vol. 231, pp. 100-107
2020
-
Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial
Schizophrenia Research, Vol. 223, pp. 271-278
-
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning
European Neuropsychopharmacology, Vol. 34, pp. 76-86
-
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): Systematic review and meta-regression analysis
Molecular Autism, Vol. 11, Núm. 1
-
Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia – data from the OPTiMiSE trial
Psychiatry Research, Vol. 289
2019
-
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study (Translational Psychiatry, (2019), 9, 1, (20), 10.1038/s41398-018-0366-5)
Translational Psychiatry
-
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
Translational Psychiatry, Vol. 9, Núm. 1
2018
-
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807
2015
-
Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: A review of current evidence and directions for future research
Schizophrenia Bulletin, Vol. 41, Núm. 3, pp. 574-583
-
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: Implications for intervention
Schizophrenia Bulletin, Vol. 41, Núm. 3, pp. 584-596
2013
-
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Schizophrenia Research, Vol. 150, Núm. 2-3, pp. 328-333
2009
-
Advantages and disadvantages of combination treatment with antipsychotics. ECNP Consensus Meeting, March 2008, Nice
European Neuropsychopharmacology, Vol. 19, Núm. 7, pp. 520-532
2006
-
Standardized remission criteria in schizophrenia
Acta Psychiatrica Scandinavica, Vol. 113, Núm. 2, pp. 91-95